(Q35687684)

9 August 2017

1 reference

title

Anti-cytokine Ab immune therapy: present status and perspectives (English)

1 reference

9 August 2017

1 reference

2

Robert C Gallo

1 reference

9 August 2017

1

Daniel Zagury

0 references

author name string

Daniel Zagury

series ordinal

1

1 reference

PubMed ID

15012931

9 August 2017

language of work or name

1 reference

1 January 2004

1 reference

9 August 2017

1 reference

9 August 2017

9

1 reference

9 August 2017

2

1 reference

9 August 2017

72-81

1 reference

The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussi

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Toward a new generation of vaccines: the anti-cytokine therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

High-avidity autoantibodies to cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Anti-IL-9 vaccination prevents worm expulsion and blood eosinophilia in Trichuris muris-infected mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Therapeutic antibodies elicited by immunization against TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Clinical trials of antibody therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Cytokine fields and the polarization of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Monoclonal antibodies in the clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Current methods for the generation of human antibodies for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

B-cell memory is short-lived in the absence of antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Continuous proliferation of murine antigen-specific helper T lymphocytes in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Preclinical efficacy and safety of pascolizumab (SB 240683): a humanized anti-interleukin-4 antibody with therapeutic potential in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Fetal effects of epidermal growth factor deficiency induced in rats by autoantibodies against epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Cytokine vaccination: neutralising IL-1alpha autoantibodies induced by immunisation with homologous IL-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Active anti-interferon-alpha immunization: a European-Israeli, randomized, double-blind, placebo-controlled clinical trial in 242 HIV-1--infected patients (the EURIS study).

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Discovery of TNF-alpha as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Differential transforming growth factor-beta secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Both E6 and E7 oncoproteins of human papillomavirus 16 inhibit IL-18-induced IFN-gamma production in human peripheral blood mononuclear and NK cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Angiogenesis Modulators Expression in Culture Cell Lines Positives for HPV-16 Oncoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Viral interleukin-10 in chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Antiproliferative action of interferon-α requires components of T-cell-receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Type I IFN modulates innate and specific antiviral immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Interferons in the persistence, pathogenesis, and treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Increased serum interferon alpha in HIV-1 associated lipodystrophy syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Relationships between natural T cells, atopy, IgE levels, and IL-4 production.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Clonal deletion of autospecific B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Breakdown of self-tolerance in anergic B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

Transgenic mice and analysis of B-cell tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2803%2902955-6

7 January 2021

10.1016/S1359-6446(03)02955-6

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15012931